Skip to main content

Peer Review reports

From: Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas

Original Submission
8 Aug 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
9 Nov 2016 Editorially accepted
22 Nov 2016 Article published 10.1186/s12885-016-2945-2

You can find further information about peer review here.

Back to article page